• Markets
    • icon
  • Companies
PNV · ASX

Polynovo Limited (ASX:PNV)

AU$2.58

 0.02 (0.781%)
ASX:Live
26/07/2024 04:10:15 PM
Recent Price downgrade Recent Earnings upgrade Hammer Bullish HALO Small HALO Price Momentum +8
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

PNV Overview

PNV Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Very Strong

Valuation

Value

Consensus

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Strong

Quality

Capital Efficiency

Neutral

Balance Sheet

Very Weak

About PNV

Website

Polynovo Limited

Telephone

61.3.8681.4050

Address

Unit 2 320 Lorimer Street Port Melbourne, Victoria (VIC) 3207

Description

Polynovo Ltd. engages in the development of medical devices, utilizing the patented polymer technology NovoSorb. It focuses on biodegradable temporizing matrix (BTM) product. It operates through the United States of America, Australia and New Zealand, and Other Countries geographical segments. The company was founded on August 12, 1998 and is headquartered in Port Melbourne, Australia.

PNV Price Chart

Key Stats

Market Cap

AU$1.84B

PE

EV/EBITDA

379.8

Dividends Overview

DIV Yield

.0%

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1.1 - 2.76

Trade Value (12mth)

AU$676,817.00

1 week

5.79%

1 month

5.79%

YTD

51.93%

1 year

61.51%

All time high

4.08

Key Fundamentals

EPS 3 yr Growth

14.300%

EBITDA Margin

-6.00%

Operating Cashflow

-$6m

Free Cash Flow Return

-11.10%

ROIC

-9.30%

Interest Coverage

-5.50

Quick Ratio

5.00

Other Data

Shares on Issue (Fully Dilluted)

699m

HALO Sector

Healthcare

Next Company Report Date

23-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

3.11

PNV Announcements

Latest Announcements

Date Announcements

23 July 24

FY24 Trading Result (unaudited)

×

FY24 Trading Result (unaudited)

24 June 24

Becoming a substantial holder

×

Becoming a substantial holder

08 May 24

First $A9M sales month and $A10M revenue month

×

First $A9M sales month and $A10M revenue month

08 May 24

Macquarie Australia Conference - Presentation

×

Macquarie Australia Conference - Presentation

06 May 24

Appointment of General Counsel & Company Secretary

×

Appointment of General Counsel & Company Secretary

26 April 24

Victorian Government Grant for Expansion of R&D Facility

×

Victorian Government Grant for Expansion of R&D Facility

10 April 24

Notification regarding unquoted securities - PNV

×

Notification regarding unquoted securities - PNV

04 March 24

India update

×

India update

28 February 24

Webcast Recording - 1H24 Results

×

Webcast Recording - 1H24 Results

27 February 24

Appendix 4D & 1H FY24 Report

×

Appendix 4D & 1H FY24 Report

27 February 24

1H FY24 Results Presentation

×

1H FY24 Results Presentation

16 February 24

Largest ever single order

×

Largest ever single order

15 February 24

Webcast Details - 1H24 Results

×

Webcast Details - 1H24 Results

22 January 24

1H24 Trading Result (unaudited)

×

1H24 Trading Result (unaudited)

10 January 24

PolyNovo presents at Annual J.P. Morgan Heathcare Conference

×

PolyNovo presents at Annual J.P. Morgan Heathcare Conference

06 December 23

First $A8M sales month and $A9M revenue month

×

First $A8M sales month and $A9M revenue month

15 November 23

Chairman address to Bell Potter Healthcare Conference

×

Chairman address to Bell Potter Healthcare Conference

07 November 23

AGM 2023 - Webcast Recording

×

AGM 2023 - Webcast Recording

03 November 23

Director Share Purchase - Robyn Elliott

×

Director Share Purchase - Robyn Elliott

03 November 23

AGM - Chairman and CEO address to shareholders

×

AGM - Chairman and CEO address to shareholders

03 November 23

Voting Results - 2023 AGM

×

Voting Results - 2023 AGM

26 October 23

PolyNovo presents at Wilsons Drug and Device Conference

×

PolyNovo presents at Wilsons Drug and Device Conference

04 October 23

Notice of Meeting - Correction to Directors Bio

×

Notice of Meeting - Correction to Directors Bio

02 October 23

BARDA increases funding US$10M

×

BARDA increases funding US$10M

02 October 23

Notice of Meeting

×

Notice of Meeting

PNV Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.01 -0.00 -0.01 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.01 -0.00 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock -11.1 74.3 -300.0 Lock Lock Lock
     PE X Lock Lock Lock Lock 9,168.3 1,155.5 13,268.0 Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock 1,591.8 0.0 379.8 Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.00 -0.00 -0.00 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.01 -0.00 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 97.6 -6,182.7 56.3 Lock Lock Lock
     Yield % Lock Lock Lock Lock -0.2 -0.3 -0.7 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.03 0.03 0.09 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.03 0.02 0.09 Lock Lock Lock
     Growth % Lock Lock Lock Lock -5.6 -21.2 277.5 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 661 661 684 Lock Lock Lock
Basic m Lock Lock Lock Lock 661 661 684 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 29 41 65 Lock Lock Lock
     Growth % Lock Lock Lock Lock 31.6 42.1 57.4 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 11 16 26 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 8 16 19 Lock Lock Lock
     Growth % Lock Lock Lock Lock 56.3 107.4 19.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock 26.8 39.2 29.6 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 73 61 70 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -2 2 -4 Lock Lock Lock
     Growth % Lock Lock Lock Lock 38.5 175.9 -353.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock -7.0 3.7 -6.0 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 1 2 2 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -3 0 -6 Lock Lock Lock
     Growth % Lock Lock Lock Lock 24.0 91.8 -2,309.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock -10.8 -0.6 -9.5 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -5 -1 -5 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -5 -1 -5 Lock Lock Lock
     Growth % Lock Lock Lock Lock -9.8 74.1 -312.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock -15.8 -2.9 -7.5 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock 0 -2 -6 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 4 0 2 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -4 6 -2 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 0 -5 48 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -4 -3 -7 Lock Lock Lock
     Growth % Lock Lock Lock Lock 58.8 33.2 -192.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock -0.1 -0.1 -0.1 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 8 6 47 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 38 35 93 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 7 9 14 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock 2 5 -31 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 16 17 27 Lock Lock Lock
Equity $m Lock Lock Lock Lock 22 18 65 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 29 27 80 Lock Lock Lock
     Growth % Lock Lock Lock Lock 4.5 -8.7 195.4 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -12.0 -3.4 -5.3 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -20.6 -6.7 -7.5 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -9.5 -0.8 -11.2 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -16.0 -4.2 -9.3 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -0.9 -7.3 -11.1 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock -6.3 4.9 -5.5 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock -1.1 3.1 7.9 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock 10.1 27.3 -47.2 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 1.9 2.1 5.3 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 1.6 1.7 5.0 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 48.1 38.3 69.6 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -2.9 -26.5 -46.8 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 6.1 7.0 6.5 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 13.4 11.2 13.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 3.9 5.0 1.2 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 6.2 4.5 4.2 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.8 1.2 0.7 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.8 1.2 0.7 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -15.6 -2.8 -7.6 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -11.9 -3.3 -5.3 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -12.0 -3.4 -5.3 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.7 2.0 1.4 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -20.6 -6.7 -7.5 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -20.6 -6.7 -7.5 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 27.2 32.5 28.1 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 60.0 51.8 56.3 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 87.2 84.3 84.4 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 28.3 26.1 17.6 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 58.9 58.3 66.8 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

.0%

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

3.11%

Value ($M)

52

Prior Change

N/A

7 Day Change

-0.20%

1 Month Change

-0.30%

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

PNV Shortsell

Frequently Asked Questions

The current share price of Polynovo Limited (PNV:ASX) is AU$2.58.
The 52-week high share price for Polynovo Limited (PNV:ASX) is AU$2.76.
The 52-week low share price for Polynovo Limited (PNV:ASX)? is AU$1.10.
The current TTM dividend payout for Polynovo Limited (PNV:ASX) is 0.00.
Polynovo Limited (PNV:ASX) does not pay a dividend.
Polynovo Limited (PNV:ASX) has a franking level of 0.0%.
Polynovo Limited (PNV:ASX) is classified in the Healthcare.
The current P/E ratio for Polynovo Limited (PNV:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.